Vimarsana
Biggest News Aggregation in the World

Page 3 - Cannabinoid Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cannabinoid Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cannabinoid Technologies Today - Breaking & Trending Today

Deliveroo and cannabis specialist among year's worst performing London floats - Vimarsana News

Deliveroo and cannabis specialist among year's worst performing London floats

More than one in three stock market debuts are trading below their listing price

Snoop Dogg Helps Double Cannabis Company's Valuation To $3.75B - Vimarsana News

Snoop Dogg Helps Double Cannabis Company's Valuation To $3.75B

Snoop Dogg's investment in cannabis tech company Dutchie is proving worthwhile with the Oregon-based firm now valued at $3.75 billion.

Investegate |Bloom Point Partners Announcements | Bloom Point Partners: INVITATION: Cannabis Invest UK Conference June 24 - Vimarsana News

Investegate |Bloom Point Partners Announcements | Bloom Point Partners: INVITATION: Cannabis Invest UK Conference June 24

Investegate announcements from Bloom Point Partners, INVITATION: Cannabis Invest UK Conference June 24

Snoop Dogg-Backed Medical Cannabis Co. Commences Trading In London, Raises $23.4 Million As Shares Soar In Early Trading - Vimarsana News

Snoop Dogg-Backed Medical Cannabis Co. Commences Trading In London, Raises $23.4 Million As Shares Soar In Early Trading

Oxford Cannabinoid Technologies, backed by Snoop Dogg, launched Friday on the London Stock Exchange wit...

Snoop Dogg-Backed Medical Cannabis Co. Commences Trading In London, Raises $23.4M As Shares Soar In Early Trading - Vimarsana News

Snoop Dogg-Backed Medical Cannabis Co. Commences Trading In London, Raises $23.4M As Shares Soar In Early Trading

Oxford Cannabinoid Technologies, backed by  Snoop Dogg, launched Friday on the London Stock Exchange with the opening price of 5 pence per share. The British company placed 960.4 million shares at 5 pence per share, suggesting a market cap of around £48 million ($69.1 million), reported the From its initial public offering, the cannabinoid-focused pharmaceutical company raised gross proceeds of £16.5 million. Oxford Cannabinoid Technologies (OCT) launched in 2017 and has been collaborating with Oxford University, mainly focusing on the development of pain-relieving, cannabinoid medica...